Table 2 : Comparison of parameters of CGM and clinical characteristics among three regimens.


  PHI70/30 LM25 LM50

6am-11am      
MIG (mmol/L) 9.5±2.4 8.9±1.6 9.1±2.5
LAGE(mmol/L) 8.7±3.0 9.8±2.7 8.2±4.0
MAGE (mmol/L) 5.3±3.2 4.8±3.0 4.5±2.8
11am-16pm      
MIG (mmol/L) 10.2±2.7 10.1±1.6 9.8±2.8
LAGE (mmol/L) 9.3±3.7 11.6±4.0 8.9±3.5
MAGE (mmol/L) 3.8±1.9 4.8±1.9 3.5±2.4
16pm-22pm      
MIG (mmol/L) 9.9±2.4 10.0±1.3 10.0±3.0
LAGE (mmol/L) 10.2±3.6 11.2±4.2 8.9±3.5
MAGE (mmol/L) 4.8±3.1 4.3±2.5 3.4±1.8
22pm-6am      
MIG (mmol/L) 8.4±2.1 8.3±1.7 8.1±2.7
LAGE (mmol/L) 8.3±3.4 9.8±2.8 6.9±3.1Δ
MAGE (mmol/L) 2.6±1.6 4.0±3.0 2.2±1.9Δ
MIG in whole day (mmol/L) 9.4±2.2 9.2±1.1 9.1±2.6
MAGE in whole day (mmol/L) 5.75±3.46 6.55±2.76 5.06±2.61
HbA1c (%) 7.4±0.7 7.5±0.9 7.4±0.9
SBP (mmHg) 128±22 127±15 125±18
DBP (mmHg) 75±11 77±9 77±9
Weight change (kg) - -0.25±1.79 0.62±1.97
Waist circumference change (cm) - 0.84±2.46 1.00±2.40
Total insulin dose (U/day) 36.6±10.7 37.2±12.2 38.3±10.6
Mean insulin dose (U/kg/day) 0.55±0.14 0.55±0.16 0.57±0.15

*: vs. PHI70/30, P<0.05; Δ: vs. LM25, P<0.05. 7.

Li et al.Journal of Diabetes Research and Clinical Metabolism  2013 2:15DOI : 10.7243/2050-0866-2-15